DA Davidson raised the firm’s price target on Ametek to $195 from $189 and keeps a Buy rating on the shares after its Q4 earnings beat. Despite some already-known, ongoing destocking with automation OEM customers and within certain areas of the medtech space, AME‘s business remains strong, led by a broad base of secularly-driven end markets, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AME: